Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Note 9 - Other Expenses (Tables)

v3.10.0.1
Note 9 - Other Expenses (Tables)
 6 Months Ended
Jun. 30, 2018
Statement Line Items [Line Items]  
Disclosure of components of research and development expense [text block]
    Three months ended
June 30,		   Six months ended
June 30,
      2018       2017       2018       2017  
Program costs, excluding salaries   $
2,201
     $
692
     $
4,476
     $
1,939
  
Salaries    
457
      
314
      
946
      
743
  
License fee, CrystalGenomics (note 9(a),(b))    
5,000
      
-
      
5,000
      
-
  
Stock-based compensation    
152
      
73
      
519
      
123
  
Depreciation and amortization    
8
      
9
      
17
      
18
  
    $
7,818
     $
1,088
     $
10,958
     $
2,823
  
Disclosure of components of general and administrative expense [text block]
    Three months ended
June 30,		   Six months ended
June 30,
      2018       2017       2018       2017  
General and administrative excluding salaries   $
1,003
     $
560
     $
2,296
     $
1,268
  
Salaries    
533
      
443
      
1,074
      
1,301
  
Stock-based payment financing fees (note 6(a)(iii)    
600
      
-
      
600
      
-
  
Stock-based compensation    
364
      
376
      
2,225
      
386
  
Depreciation and amortization    
11
      
14
      
18
      
28
  
    $
2,511
     $
1,393
     $
6,213
     $
2,983
  
Disclosure of finance income (cost) [text block]
    Three months ended
June 30,		   Six months ended
June 30,
      2018       2017       2018       2017  
Foreign exchange loss   $
11
     $
-
     $
28
     $
-
  
    Three months ended
June 30,		   Six months ended
June 30,
      2018       2017       2018       2017  
Interest income   $
74
     $
11
     $
118
     $
19
  
Foreign exchange gain    
-
      
29
      
-
      
54
  
    $
74
     $
40
     $
118
     $
73